Hodgkin’s Lymphoma: An Environmental Scan
Table of Contents
Bibliographic Resource: Report Citations
Adamson, Peter, and Richard McNally. 2005. Hodgkin’s Disease. In Cancer Atlas of the United Kingdom and Ireland 1991–2000, 208. Great Britian: Palgrave Macmillian.
Alexander. 1990. Clustering and Hodgkin’s disease. British Journal of Cancer 62, no. 5 (November): 708-711.
Alexander, F, P McKinney, J Williams, J Ricketts, and R Cartwright. 1991. Epidemiological Evidence for the ‘Two-Disease Hypothesis’ in Hodgkin’s Disease. Int. J. Epidemiol. 20, no. 2 (June 1): 354-361.
Allemani, Claudia, Milena Sant, Roberta De Angelis, Rafael Marcos-Gragera, and Jan Willem Coebergh. 2006. Hodgkin disease survival in Europe and the U.S.: prognostic significance of morphologic groups. Cancer 107, no. 2 (July 15): 352-360.
American Cancer Society. 2007. Cancer Facts & Figures 2007. http://www.cancer.org/Research/CancerFactsFigures/cancer-facts-figures-2007.
Ariad, Samuel, Irena Lipshitz, Daniel Benharroch, Jacob Gopas, and Micha Barchana. 2009. A sharp rise in the incidence of Hodgkin’s lymphoma in young adults in Israel. The Israel Medical Association Journal: IMAJ 11, no. 8 (August): 453-455.
Assouline, Sarit, and Wilson H. Miller. 2006. High-dose vitamin C therapy: Renewed hope or false promise? CMAJ 174, no. 7 (March 28): 956-957.
Aster, Jon. 2010. Epidemiology, pathologic features, and diagnosis of classical Hodgkin lymphoma. June 15. http://www.uptodate.com/patients/content/topic.do?topicKey=~GzFGFokybpNyx1U#H3.
Bendall, J. 2010. Editorial [Hot topic: New and Emerging Drug Targets for the Treatment of Hematological Malignancies (Guest Editors: Dr. Linda J. Bendall)]. Current Drug Targets 11, no. 7: 767–768.
Böll, Boris, Peter Borchmann, and Volker Diehl. 2010. Emerging drugs for Hodgkin’s lymphoma. Expert Opinion on Emerging Drugs (July 15).
Booth, Christopher M., Gavin Li, Jina Zhang-Salomons, and William J. Mackillop. 2010. The impact of socioeconomic status on stage of cancer at diagnosis and survival. Cancer
Campbell, Colin. 2008a. Research Methodology in Cancer Research. http://www.tcolincampbell.org/courses-resources/article/research-methodology-in-cancer-research/browse/2/category/oncology-1/?tx_ttnews%5BbackPid%5D=76&cHash=c29c5b74e1.
———. 2008b. China Report: Cholesterol and Cancer. http://www.tcolincampbell.org/courses-resources/article/china-report-cholesterol-and-cancer/browse/1/?tx_ttnews%5BbackPid%5D=76&cHash=1f8ee5dc5b.
———. 2008c. Lymphoma. http://www.tcolincampbell.org/courses-resources/article/lymphoma-1/browse/3/?tx_ttnews%5BbackPid%5D=76&cHash=5756ee2044.
———. 2010. It’s Time for an NIH Institute for Nutrition. The Huffington Post. July 24. http://www.huffingtonpost.com/t-colin-campbell/its-time-for-an-nih-insti_b_637080.html?utm_source=Master+List&utm_campaign=f1c798822f-Newsletter_June_2010_tracking&utm_medium=email.
Canadian Cancer Society, Statistics Canada, Provincial/Territorial Cancer Registries, and Public Health Agency of Canada. 2010. Canadian Cancer Statistics 2010: Special Topic: End of Life Care. Canadian Cancer Society. www.cancer.ca/statistics.
Cartwright, and Watkins. 2004. Epidemiology of Hodgkin’s disease: A review. Hematological Oncology 22: 11-26.
Chow, S. S, and Y. Huang. 2010. Editorial [Hot topic: Utilizing Chinese Medicines to Improve Cancer Therapy-Fiction or Reality?(Guest Editors: Ying Huang and Moses Sing Sum Chow)]. Current Drug Discovery Technologies 7, no. 1: 1–1.
Clarke, Christina A, Sally L Glaser, Theresa H M Keegan, and Antoinette Stroup. 2005. Neighborhood socioeconomic status and Hodgkin’s lymphoma incidence in California. Cancer Epidemiology, Biomarkers & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology 14, no. 6 (June): 1441-1447.
Cuenca, X, A Xhaard, and N Mounier. 2009. [Prognostic factors in Hodgkin and non-Hodgkin lymphomas]. Bulletin Du Cancer 96, no. 4 (April): 461-473.
DeVita, Vincent T., and Jose Costa. 2010. Toward a Personalized Treatment of Hodgkin’s Disease. N Engl J Med 362, no. 10 (March 11): 942-943.
Diehl, and Fuchs. 2007. Early, intermediate and advanced Hodgkin’s lymphoma: modern treatment strategies. Annals of Oncology: Official Journal of the European Society for Medical Oncology / ESMO 18 Suppl 9 (July): ix71-79.
Diepstra, A, M Niens, G J te Meerman, S Poppema, and A van den Berg. 2005. Genetic susceptibility to Hodgkin’s lymphoma associated with the human leukocyte antigen region. European Journal of Haematology. Supplementum, no. 66 (July): 34-41.
Engert, A., D. A. Eichenauer, M. Dreyling, and On behalf of the ESMO Guidelines Working Group. 2009. Hodgkin’s lymphoma: ESMO Clinical Recommendations for diagnosis, treatment and follow-up. Annals of Oncology 20, no. 4 (5): iv108-iv109.
Garland, Cedric F, Edward D Gorham, Sharif B Mohr, and Frank C Garland. 2009. Vitamin D for cancer prevention: global perspective. Annals of Epidemiology 19, no. 7 (July): 468-483.
Gianni, Alessandro M., Marco Bregni, Salvatore Siena, Cristina Brambilla, Massimo Di Nicola, Fabrizio Lombardi, Lorenza Gandola, et al. 1997. High-Dose Chemotherapy and Autologous Bone Marrow Transplantation Compared with MACOP-B in Aggressive B-Cell Lymphoma. N Engl J Med 336, no. 18 (May 1): 1290-1298.
Glaser, Sally L., Christina A. Clarke, Rebecca A. Nugent, Cynthia B. Stearns, and Ronald F. Dorfman. 2002. Social class and risk of Hodgkin’s disease in young-adult women in 1988-94. International Journal of Cancer 98, no. 1: 110-117. doi:10.1002/ijc.10164.
Glaser, Sally L., and William G. Swartz. 1990. Time trends in Hodgkin’s disease incidence: The role of diagnostic accuracy. Cancer 66, no. 10: 2196-2204.
Goldin, L R, M L McMaster, M Ter-Minassian, S Saddlemire, B Harmsen, G Lalonde, and M A Tucker. 2005. A genome screen of families at high risk for Hodgkin lymphoma: evidence for a susceptibility gene on chromosome 4. Journal of Medical Genetics 42, no. 7 (July): 595-601.
Grulich, Andrew E, Marina T van Leeuwen, Michael O Falster, and Claire M Vajdic. 2007. Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. The Lancet 370, no. 9581 (7): 59-67.
Gutensohn, NM. 1982. Social class and age at diagnosis of Hodgkin’s dis… [Cancer Treat Rep. 1982] – PubMed result. Cancer Treatment Reports 66.
Haddad, J. 2009. The Efficacy and Safety of CAAT (Controlled Amino Acid Therapy) On Cancer Cells -. Artipot. http://www.artipot.com/articles/339720/the-efficacy-and-safety-of-caat-controlled-amino-acid-therapy-on-cancer-cells.htm.
Hjalgrim, Henrik, Johan Askling, Per Sorensen, Mette Madsen, Nils Rosdahl, Hans H. Storm, Stephen Hamilton-Dutoit, et al. 2000. Risk of Hodgkin’s Disease and Other Cancers After Infectious Mononucleosis. J. Natl. Cancer Inst. 92, no. 18 (September 20): 1522-1528.
Hodgson, David C., Eva Grunfeld, Nadia Gunraj, and Lisa Del Giudice. 2010. A population-based study of follow-up care for Hodgkin lymphoma survivors. Cancer
Klimm, Beate, Volker Diehl, and Andreas Engert. 2007. Hodgkin’s lymphoma in the elderly: a different disease in patients over 60. Oncology (Williston Park, N.Y.) 21, no. 8 (July): 982-990.
Kreitman, Robert J., and Ira Pastan. 2006. Immunotoxins in the Treatment of Hematologic Malignancies. Current Drug Targets 7, no. 10 (October): 1301-1311.
Kulie, Teresa, Amy Groff, Jackie Redmer, Jennie Hounshell, and Sarina Schrager. 2009. Vitamin D: an evidence-based review. Journal of the American Board of Family Medicine: JABFM 22, no. 6 (December): 698-706.
Küppers, Ralf, Joachim Yahalom, and Andreas Josting. 2006. Advances in biology, diagnostics, and treatment of Hodgkin’s disease. Biology of Blood and Marrow Transplantation: Journal of the American Society for Blood and Marrow Transplantation 12, no. 1 (January): 66-76.
Lacroix, Aurélie, Arnaud Jaccard, Christine Rouzioux, Christophe Piguet, Barbara Petit, Dominique Bordessoule, and Sylvie Ranger-Rogez. 2007. HHV-6 and EBV DNA quantitation in lymph nodes of 86 patients with Hodgkin’s lymphoma. Journal of Medical Virology 79, no. 9 (September): 1349-1356.
Lee, Alfred Ian, Dan S. Zuckerman, Annick D. Van den Abbeele, Suzanne L. Aquino, Diane Crowley, Christiana Toomey, Ann S. Lacasce, Yang Feng, Donna S. Neuberg, and Ephraim P. Hochberg. 2010. Surveillance imaging of Hodgkin lymphoma patients in first remission. Cancer.
Lucas, David, Patrick Still, Lynette Bueno Perez, Michael Grever, and A. Douglas Kinghorn. 2010. Potential of Plant-Derived Natural Products in the Treatment of Leukemia and Lymphoma. Current Drug Targets 11, no. 7 (7): 812-822.
Lymphoma Research Foundation. 2009. Understanding Hodgkin Lymphoma: A Guide for patients, Survivors and Loved Ones. 3rd ed. New York, NY: Lymphoma Research Foundation.
Mack, Thomas M., Wendy Cozen, Darryl K. Shibata, Lawrence M. Weiss, Bharat N. Nathwani, Antonio M. Hernandez, Clive R. Taylor, Ann S. Hamilton, Dennis M. Deapen, and Edward B. Rappaport. 1995. Concordance for Hodgkin’s Disease in Identical Twins Suggesting Genetic Susceptibility to the Young-Adult Form of the Disease. N Engl J Med 332, no. 7 (February 16): 413-419.
Mani, Haresh, and Elaine S Jaffe. 2009. Hodgkin lymphoma: an update on its biology with new insights into classification. Clinical Lymphoma & Myeloma 9, no. 3 (June): 206-216.
Myrehaug, Sten, Melania Pintilie, Richard Tsang, Robert Mackenzie, Michael Crump, Zhongliang Chen, Alexander Sun, and David C Hodgson. 2008. Cardiac morbidity following modern treatment for Hodgkin lymphoma: supra-additive cardiotoxicity of doxorubicin and radiation therapy. Leukemia & Lymphoma 49, no. 8 (August): 1486-1493.
National Cancer Institue. 2010. Hodgkin Lymphoma. May 15. http://www.cancer.gov/cancertopics/types/hodgkin.
National Cancer Institute. 2007a. Surveillance Epidemiology and End Results: Hodgkin Lymphoma 2007. SEER Cancer Government Statistics. http://www.seer.cancer.gov/csr/1975_2007/results_single/sect_01_table.01.pdf.
———. 2007b. What You Need To Know About™ Hodgkin Lymphoma. U.S. Department of Health and Human Services.
———. 2009. Vitamin C as a Potential Anti-Cancer Agent: Progress and Controversies. Office of Cancer Complementary and Alternative Medicine 4, no. 1. http://www.cancer.gov/cam/newsletter/2009-spring/research_highlights.html.
Nogová, Lucia, Thomas Rudiger, and Andreas Engert. 2006. Biology, clinical course and management of nodular lymphocyte-predominant hodgkin lymphoma. Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program: 266-272.
Ohno, SATOSHI, Y Ohno, N Suzuki, G Soma, and M Inoue. 2009. High-dose Vitamin C (Ascorbic Acid) Therapy in the Treatment of Patients with Advanced Cancer. Anticancer Research 29, no. 3 (March): 809-815.
Padayatty, Sebastian J., Hugh D. Riordan, Stephen M. Hewitt, Arie Katz, L. John Hoffer, and Mark Levine. 2006. Intravenously administered vitamin C as cancer therapy: three cases. CMAJ 174, no. 7 (March 28): 937-942.
Pahwa, Punam, Chandima P Karunanayake, John J Spinelli, James A Dosman, and Helen H McDuffie. 2009. Ethnicity and incidence of Hodgkin lymphoma in Canadian population. BMC Cancer 9: 141.
Paltiel, Ora. 2008. Family matters in Hodgkin lymphoma. Leukemia & Lymphoma 49, no. 7 (July): 1234-1235.
Persky, Daniel O. 2007. Dx/Rx. Sudbury, Massachusetts: Jones & Bartlett Learning.
Pollard, HARVEY B., MARK A. Levine, OFER Eidelman, and MORRIS Pollard. 2010. Pharmacological Ascorbic Acid Suppresses Syngeneic Tumor Growth and Metastases in Hormone-refractory Prostate Cancer. In Vivo 24, no. 3 (May): 249-255.
Porojnicu, A C, T E Robsahm, A H Ree, and J Moan. 2005. Season of diagnosis is a prognostic factor in Hodgkin’s lymphoma: a possible role of sun-induced vitamin D. British Journal of Cancer 93, no. 5 (September 5): 571-574.
Provencio, Mariano, Isabel Millán, Pilar España, Antonio C Sánchez, José J Sánchez, Blanca Cantos, Juan A Vargas, et al. 2008. Analysis of competing risks of causes of death and their variation over different time periods in Hodgkin’s disease. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 14, no. 16 (August 15): 5300-5305.
Punnett, Angela, Richard W Tsang, and David C Hodgson. 2010. Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects. Seminars in Radiation Oncology 20, no. 1 (January): 30-44.
Raabe, Eric, and Julia Kim. 2010. Vaccination as a Tool for Cancer Prevention. WedMD. July 15. http://www.medscape.com/viewarticle/725132.
Raemaekers, J. M. M., and R. W. M. van der Maazen. 2008. Hodgkin’s lymphoma: news from an old disease. Netherlands Journal of Medicine 66: 457.
Sánchez-Espiridión, Beatriz, Abel Sánchez-Aguilera, Carlos Montalbán, Carmen Martin, Rafael Martinez, Joaquín González-Carrero, Concepción Poderos, et al. 2009. A TaqMan low-density array to predict outcome in advanced Hodgkin’s lymphoma using paraffin-embedded samples. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research 15, no. 4 (February 15): 1367-1375.
Savoldo, Barbara, Cliona M Rooney, Antonio Di Stasi, Hinrich Abken, Andreas Hombach, Aaron E Foster, Lan Zhang, Helen E Heslop, Malcolm K Brenner, and Gianpietro Dotti. 2007. Epstein Barr virus specific cytotoxic T lymphocytes expressing the anti-CD30zeta artificial chimeric T-cell receptor for immunotherapy of Hodgkin disease. Blood 110, no. 7 (October 1): 2620-2630.
Seam, Pamela, John E. Janik, Dan L. Longo, and Vincent T. DeVita. 2009. Role of Chemotherapy in Hodgkin’s Lymphoma. The Cancer Journal 15, no. 2 (3): 150-154.
Siddiqui, Neelam, Bilal Ayub, Farhana Badar, and Alia Zaidi. 2006. Hodgkin’s lymphoma in Pakistan: a clinico-epidemiological study of 658 cases at a cancer center in Lahore. Asian Pacific Journal of Cancer Prevention: APJCP 7, no. 4 (December): 651-655.
Soares, Andrea, Irene Biasoli, Adriana Scheliga, Ronir Raggio Luiz, Mário Alberto Costa, Marcelo Land, Sérgio Romano, José Carlos Morais, and Nelson Spector. 2007. Socioeconomic inequality and short-term outcome in Hodgkin’s lymphoma. International Journal of Cancer 120, no. 4 (2): 875-879.
Staege, Martin S, Ursula Banning-Eichenseer, Grit Weissflog, Ines Volkmer, Stefan Burdach, Günther Richter, Christine Mauz-Körholz, Jürgen Föll, and Dieter Körholz. 2008. Gene expression profiles of Hodgkin’s lymphoma cell lines with different sensitivity to cytotoxic drugs. Experimental Hematology 36, no. 7 (July): 886-896.
Steidl, Christian, Tang Lee, Sohrab P. Shah, Pedro Farinha, Guangming Han, Tarun Nayar, Allen Delaney, et al. 2010. Tumor-Associated Macrophages and Survival in Classic Hodgkin’s Lymphoma. N Engl J Med 362, no. 10 (March 11): 875-885.
Torjman, Lamia, Saloua Ladeb, Amel Lakhal, Tarek Ben Othman, Abderrahman Abdelkefi, and Abdeladhim Ben Abdeladhim. 2007. High-dose therapy and autologous stem cell transplantation for Hodgkin’s lymphoma in relapse or failure after initial chemotherapy : results of the Centre National de Greffe de Moelle Osseuse de Tunis. La Tunisie Médicale 85, no. 1 (January): 35-38.
USAD. 2010. Dietary Guidelines for Americans. In . United States: USAD, June.
Van Vlierberghe, Pieter, An De Weer, Pieter Mestdagh, Tom Feys, Katleen De Preter, Pascale De Paepe, Kathleen Lambein, et al. 2009. Comparison of miRNA profiles of microdissected Hodgkin/Reed-Sternberg cells and Hodgkin cell lines versus CD77+ B-cells reveals a distinct subset of differentially expressed miRNAs. British Journal of Haematology 147, no. 5 (December): 686-690.
Vestergaard, Hanne, Tine Westergaard, Jan Wohlfahrt, Henrik Hjalgrim, and Mads Melbye. 2010. Tonsillitis, tonsillectomy and Hodgkin’s lymphoma. International Journal of Cancer.
Weiss, L A Movahed, R A Warnke, and J Sklar. 1989. Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin’s disease. The New England Journal of Medicine 320, no. 8 (February 23): 502-506.
Weiss, J G Strickler, R A Warnke, D T Purtilo, and J Sklar. 1987. Epstein-Barr viral DNA in tissues of Hodgkin’s disease. The American Journal of Pathology 129, no. 1 (October): 86-91.
Zintzaras, Elias, Michael Voulgarelis, and Haralampos M. Moutsopoulos. 2005. The Risk of Lymphoma Development in Autoimmune Diseases: A Meta-analysis. Arch Intern Med 165, no. 20 (November 14): 2337-2344.